Feature | August 06, 2014

Medtronic, Acist Enter Agreement to Commercialize Next Generation FFR-IVUS Technologies

Collaboration provides increased commercial reach, brand synergies and customer access to new technologies

Medtronic, Acist Agreement FFR-IVUS Technologies

August 6, 2014  — Acist Medical Systems announced it entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States. Under this agreement, Acist and Medtronic will work collaboratively to introduce these groundbreaking products into cardiac catheterization laboratories across the United States.

Fractional flow reserve (FFR) has quickly become the standard that interventional cardiologists use to determine which patients can most benefit from stenting. Intravascular ultrasound (IVUS) is an advanced diagnostic modality that provides greater insight into arterial disease than standard angiography alone. The Acist RXi and HDi systems are quicker, easier to use and offer detailed insight that physicians can use to optimize treatment choice for their patients.

Through this collaboration, Acist and Medtronic will bring this technology to existing and new customers who value improved modalities that simplify procedures and benefit their patients.

Acist’s new Rapid FFR system, which utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console, was introduced earlier this year in the United States and Europe. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, and the RXi system facilitates rapid FFR assessments before, during and post-intervention. This technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.

This agreement makes Acist/Medtronic the forth vendor for FFR and IVUS systems in the U.S. market.

For more information: www.acist.com, www.bracco.com, www.medtronic.com

Related Content

Sponsored Content | Videos | TCT| November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies
COLOR trial, TCT, NIRS, stenting vulnerable plaques, near infrared spectroscopy

An intravascular ultrasound image (IVUS) with co-registered NIRS showing yellow for the detection of lipid rich plaque in a coronary artery. 

News | Cath Lab| November 07, 2016
November 7, 2016 – Two-year results from the COLOR Trial, the first large-scale multicenter prospective study of its
Philips, TCT 2016, image guidance technologies, iFR, HeartNavigator
News | Cath Lab| October 26, 2016
Philips recently announced its latest image guidance solutions to be featured at the 2016 Transcatheter Cardiovascular...
St. Jude Medical, PressureWire X Guidewire, FDA, launch, FFR catheter
Technology | FFR Catheters| October 10, 2016
St. Jude Medical Inc. announced the U.S. clearance and launch of the company’s new PressureWire X Guidewire fractional...
Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab
News | Cath Lab| August 17, 2016
Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn...
bioresorbable stent, bioabsorbable stent, Absorb BVS, visualizing bioresorbable stents

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system

 

Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of inter
3-D OCT

A 3-D OCT rendering of a stented vessel segment created on St. Jude Medical's Ilumien Optis OCT system. 

Feature | Angiography| July 15, 2016 | Dave Fornell
While angiographic X-ray fluoroscopy systems are the workhorse for transcatheter cardiovascular interventional proced
HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab| May 19, 2016
St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR 2016.
vulnerable plaques, OCT, IVUS, catheter, combination, NIBIB study

The dual catheter OCT-IVUS imaging device can be inserted into an artery to simultaneously capture an infrared image of the arterial wall (OCT, at left) and an ultrasound image (IVUS, right) that doctors use to determine the potential that a plaque is susceptible to rupture that could cause a heart attack or stroke.

News | Intravascular Imaging| May 12, 2016
May 12, 2016 — Collaboration between two National Institute of Biomedical Imaging and Bioengineering (NIBIB)-funded l
Overlay Init